Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hepatitis c virus AND infection:

Search results

Items: 1 to 20 of 30421

1.

Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two.

Gheorghe L, Sporea I, Iacob S, Sirli R, Trifan A, Diculescu M, Stanciu C, Pascu O, Acalovschi M, Brisc C, Cijevschi C, Gheorghe C, Spârchez Z, Rogoveanu I, Dobru D, Dumitrascu DL.

J Gastrointestin Liver Dis. 2017 Sep;26(3):309-317. doi: 10.15403/jgld.2014.1121.263.rom.

PMID:
28922445
2.

Clinical profile of hepatitis C virus infection in a developing country- India.

Mahajan R, Midha V, Goyal O, Mehta V, Narang V, Kaur K, Singh A, Singh D, Bhanot R, Sood A.

J Gastroenterol Hepatol. 2017 Sep 18. doi: 10.1111/jgh.13995. [Epub ahead of print]

PMID:
28921677
3.

Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation.

Szymanek-Pasternak A, Rostkowska K, Simon K.

BMJ Case Rep. 2017 Sep 15;2017. pii: bcr-2017-220152. doi: 10.1136/bcr-2017-220152.

PMID:
28918403
4.

Hepatic immunopathology during occult hepacivirus re-infection.

Manickam C, Martinot AJ, Jones RA, Varner V, Reeves RK.

Virology. 2017 Sep 12;512:48-55. doi: 10.1016/j.virol.2017.08.037. [Epub ahead of print]

PMID:
28915405
5.

Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.

Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D'Agnone O, Alho H, Rolland B.

Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000962. [Epub ahead of print]

PMID:
28914697
6.

The IRES5'UTR of the dicistrovirus cricket paralysis virus is a type III IRES containing an essential pseudoknot structure.

Gross L, Vicens Q, Einhorn E, Noireterre A, Schaeffer L, Kuhn L, Imler JL, Eriani G, Meignin C, Martin F.

Nucleic Acids Res. 2017 Sep 6;45(15):8993-9004. doi: 10.1093/nar/gkx622.

PMID:
28911115
7.

Succesful treatment of chronic hepatitis C virus infection with daclatasvir and asunaprevir in a transfusion dependent thalassaemia patient.

Köklü H, Köklü S, Ozturk O, Aksoy EK, Tseveldorj N.

Acta Gastroenterol Belg. 2016 Sep-Dec;79(4):501-502. No abstract available.

PMID:
28906223
8.

A Novel Genetic Group of Bovine <i>Hepacivirus</i> in Archival Serum Samples from Brazilian Cattle.

Canal CW, Weber MN, Cibulski SP, Silva MS, Puhl DE, Stalder H, Peterhans E.

Biomed Res Int. 2017;2017:4732520. doi: 10.1155/2017/4732520. Epub 2017 Aug 20.

PMID:
28904959
9.

Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation.

Ito M, Sun S, Fukuhara T, Suzuki R, Tamai M, Yamauchi T, Nakashima K, Tagawa YI, Okazaki S, Matsuura Y, Wakita T, Suzuki T.

Oncotarget. 2017 Jul 8;8(33):53899-53915. doi: 10.18632/oncotarget.19108. eCollection 2017 Aug 15.

PMID:
28903311
10.

The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.

Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG; Women’s Interagency HIV Study.

PLoS One. 2017 Sep 13;12(9):e0181004. doi: 10.1371/journal.pone.0181004. eCollection 2017.

11.

Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.

Smolders EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):193-199. doi: 10.1097/QAI.0000000000001488.

PMID:
28902678
12.

Exposure source prevalence is associated with gender in hepatitis C virus patients from Rio de Janeiro, Brazil.

Olmedo DB, Precioso PM, Lugdero-Correia A, Silva GD, Santos AMGD, Pôrto LC.

Mem Inst Oswaldo Cruz. 2017 Sep;112(9):632-639. doi: 10.1590/0074-02760160553.

13.

Recent advancement of Direct-acting antiviral agents (DAAs) in Hepatitis C therapy.

Das D, Pandya M.

Mini Rev Med Chem. 2017 Sep 12. doi: 10.2174/1389557517666170913111930. [Epub ahead of print]

PMID:
28901852
14.

SOCS1 is an inducible negative regulator of IFN lambda induced gene expression in vivo.

Blumer T, Coto-Llerena M, Duong FHT, Heim MH.

J Biol Chem. 2017 Sep 12. pii: jbc.M117.788877. doi: 10.1074/jbc.M117.788877. [Epub ahead of print]

15.

Tumour viruses and innate immunity.

Hopcraft SE, Damania B.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). pii: 20160267. doi: 10.1098/rstb.2016.0267. Review.

PMID:
28893934
16.

Tumour virus epidemiology.

Lunn RM, Jahnke GD, Rabkin CS.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). pii: 20160266. doi: 10.1098/rstb.2016.0266. Review.

PMID:
28893933
17.

Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells.

Sakurai F, Kunito T, Takayama K, Hashimoto R, Tachibana M, Sakamoto N, Wakita T, Mizuguchi H.

Virus Res. 2017 Sep 9;242:7-15. doi: 10.1016/j.virusres.2017.09.004. [Epub ahead of print]

PMID:
28893653
18.

Beclabuvir in combination with asunaprevir and daclatasvir for hepatitis C virus genotype 1 infection: A systematic review and meta-analysis.

Ahmed AM, Doheim MF, Mattar OM, Sherif NA, Truong DH, Le Hoa PT, Hirayama K, Huy NT.

J Med Virol. 2017 Sep 11. doi: 10.1002/jmv.24947. [Epub ahead of print]

PMID:
28892235
19.

Interferon-α induces negative biases in emotional processing in patients with hepatitis C virus infection: a preliminary study.

Cooper CM, Godlewska B, Sharpley AL, Barnes E, Cowen PJ, Harmer CJ.

Psychol Med. 2017 Sep 11:1-10. doi: 10.1017/S0033291717002379. [Epub ahead of print]

PMID:
28889805
20.

Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.

Grebely J, Bruneau J, Bruggmann P, Harris M, Hickman M, Rhodes T, Treloar C; International Network on Hepatitis in Substance Users; International Network on Hepatitis in Substance Users.

Int J Drug Policy. 2017 Sep;47:26-33. doi: 10.1016/j.drugpo.2017.08.001. No abstract available.

PMID:
28888558

Supplemental Content

Loading ...
Support Center